trial · primary record
VE303
Clostridium Difficile
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 852 |
| Primary completion | 2027-10 |
| Primary endpoint | CDI Recurrence Rate at Week 8 |
| Registry ID | NCT06237452 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:41:21.461Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06237452
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.